Home The Word Brain My Amedeo FAQ Privacy About   


Hanzi Hunter — ultra-fast Hanzi study

All 1,152 characters from the aioLingua manual

AbstractAboutThe 20 audio files

← aioLingua Chinese Online

← Chinese aioLingua PDF


  HIV Infection

  Free Subscription


17.11.2025

8 AIDS
1 Am J Epidemiol
7 Clin Infect Dis
4 HIV Med
2 J Infect Dis
2 J Med Virol
1 J Virol
1 Lancet
1 PLoS Biol
2 PLoS One
2 PLoS Pathog


  Retrieve available abstracts of this week’s articles:
HTML format
 
 
Single Articles


    AIDS

  1. TAHLIL KM, Pettifor AE, Edwards JK, Tang W, et al
    Uptake of facility-based HIV testing among adolescents and young adults in Nigeria.
    AIDS. 2025 Nov 12. doi: 10.1097/QAD.0000000000004393.
    PubMed         Abstract available

  2. MALAMA K, Parker R, Wall KM, Kilembe W, et al
    HIV incidence and risk factors for seroconversion among female sex workers and single mothers in a 10-year prospective cohort.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004403.
    PubMed         Abstract available

  3. DIGGS MR, Chu SM, Fitch KV, Olefsky M, et al
    Health-related quality of life among people with HIV at low-to-moderate risk for atherosclerotic cardiovascular disease in the REPRIEVE Trial.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004401.
    PubMed         Abstract available

  4. ZHU X, Patel EU, Berry SA, Lucas GM, et al
    Hospital readmissions among adults with chronic kidney disease by HIV status in the United States.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004397.
    PubMed         Abstract available

  5. KNIGHT J, Ma H, Sithole B, Khumalo L, et al
    Evaluating the impact of achieving cascade equality in Eswatini: a modelling study on the prevention impacts of antiretroviral therapy.
    AIDS. 2025 Nov 11. doi: 10.1097/QAD.0000000000004400.
    PubMed         Abstract available

  6. SHIINO T, Chikata T, Hayashida T, Tran LK, et al
    Epidemiological Links of HIV-1 CRF01_AE among Men Who Have Sex with Men in Northern Vietnam and Japan.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004406.
    PubMed         Abstract available

  7. OKHAGBUZO MI, Njuguna I, King'e M, Moraa H, et al
    Lower working memory and processing speed among children and youth exposed to HIV.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004402.
    PubMed         Abstract available

  8. LI QH, Zhao J, Hu SP, Wang FX, et al
    A novel second-generation HIV-1 circulating recombinant form (CRF183_0107) identified among men who have sex with men in China.
    AIDS. 2025 Nov 10. doi: 10.1097/QAD.0000000000004404.
    PubMed         Abstract available


    Am J Epidemiol

  9. WESTMORELAND DA, Ray MA, Sultana S, Bleasdale J, et al
    Implementing and retaining a large-scale technology-mediated cohort to study HIV incidence and PrEP uptake among vulnerable cisgender men as well as transgender individuals in the U.S., the Together 5,000 cohort.
    Am J Epidemiol. 2025 Nov 12:kwaf250. doi: 10.1093.
    PubMed         Abstract available


    Clin Infect Dis

  10. CHUNG JR, Price AM, Zimmerman RK, Moehling Geffel K, et al
    Influenza vaccine effectiveness against medically attended outpatient illness, United States, 2023-24 season.
    Clin Infect Dis. 2025 Jan 6:ciae658. doi: 10.1093.
    PubMed         Abstract available

  11. TOY M, Hutton D, Teshale E, Thompson WW, et al
    Cost-Effectiveness of One-time Universal Testing for Hepatitis D among Adults living with Chronic Hepatitis B in the United States.
    Clin Infect Dis. 2025 Apr 8:ciaf181. doi: 10.1093.
    PubMed         Abstract available

  12. CRUM N
    Let's Get It Started: Early ART after HIV Acquisition Reduces Non-AIDS-Defining Malignancies.
    Clin Infect Dis. 2025 Nov 5:ciaf596. doi: 10.1093.
    PubMed        

  13. VAN DER WULP IAJ, Wit FW, Jongen VW, Brinkman K, et al
    Earlier initiation of treatment following HIV acquisition reduces non-AIDS-defining malignancy risk.
    Clin Infect Dis. 2025 Nov 5:ciaf595. doi: 10.1093.
    PubMed         Abstract available

  14. KENYON C
    Screening for anal cancer is associated with real harms and questionable benefits.
    Clin Infect Dis. 2025 Nov 8:ciaf613. doi: 10.1093.
    PubMed        

  15. BERCOT B, Assoumou L, Camelena F, Voitichouk C, et al
    Antimicrobial drug-resistant Neisseria gonorrhoeae (GC) infections in men using doxycycline postexposure prophylaxis. A substudy of the ANRS 174 DOXYVAC trial.
    Clin Infect Dis. 2025 Nov 10:ciaf591. doi: 10.1093.
    PubMed         Abstract available

  16. CARRATALA CASTRO L, Munguambe S, Kay A, Ssengooba W, et al
    Estimating the Accuracy and Additionality of TB-LAM to Diagnose TB in Children Without HIV (AccuLAM).
    Clin Infect Dis. 2025 Nov 10:ciaf525. doi: 10.1093.
    PubMed         Abstract available


    HIV Med

  17. WHITLOCK G, Gedela K
    Who's missing from London's HIV prevention response?
    HIV Med. 2025 Nov 7. doi: 10.1111/hiv.70141.
    PubMed        

  18. KNOX C, Wright J, Levett T
    A cross-sectional comparison of the use of frailty assessment tools in older people living with HIV.
    HIV Med. 2025 Nov 13. doi: 10.1111/hiv.70125.
    PubMed         Abstract available

  19. MA Y, Lohman M, Brown MJ, Li Y, et al
    Temporal network analysis of comorbidities among people with HIV in South Carolina.
    HIV Med. 2025 Nov 12. doi: 10.1111/hiv.70147.
    PubMed         Abstract available

  20. WALDECKER M, Taghavi K, Pasin C, Tarr PE, et al
    Factors associated with uptake of gynaecological care and cervical cancer screening among women in the Swiss HIV Cohort Study.
    HIV Med. 2025 Nov 11. doi: 10.1111/hiv.70137.
    PubMed         Abstract available


    J Infect Dis

  21. HANSCOM B, Marzinke MA, Li X, Donnell D, et al
    Estimation of prevention-effective CAB-LA concentrations among men who have sex with men (MSM) and transgender women (TGW) in HPTN 083.
    J Infect Dis. 2025 Nov 5:jiaf561. doi: 10.1093.
    PubMed         Abstract available

  22. SELZER L, Demirdjian S, Falkard B, Li J, et al
    Resistance Analysis of Low-Level Virologic Rebound During HIV-1 Treatment with Lenacapavir and Broadly Neutralizing Antibodies Teropavimab and Zinlirvimab.
    J Infect Dis. 2025 Nov 5:jiaf559. doi: 10.1093.
    PubMed         Abstract available


    J Med Virol

  23. NASIR MW, Gao Y
    Advances in KSHV Research: Molecular Pathogenesis, Immune Evasion, and Evolving Therapeutic Horizon.
    J Med Virol. 2025;97:e70695.
    PubMed         Abstract available

  24. CASADO-FERNANDEZ G, de la Calle-Jimenez O, Armenteros I, Lemus Aguilar L, et al
    Changes in HIV-1 Reservoir Dynamics After Mpox Infection.
    J Med Virol. 2025;97:e70690.
    PubMed         Abstract available


    J Virol

  25. JAMIESON PJ, Shen X, Abu-Shmais AA, Wasdin PT, et al
    Glycan-reactive antibodies isolated from human HIV-1 vaccine trial participants show broad pathogen cross-reactivity.
    J Virol. 2025 Nov 10:e0125625. doi: 10.1128/jvi.01256.
    PubMed         Abstract available


    Lancet

  26. KARIM QA
    Lessons from Africa: health diplomacy in HIV prevention.
    Lancet. 2025 Nov 4:S0140-6736(25)01976-2. doi: 10.1016/S0140-6736(25)01976.
    PubMed        


    PLoS Biol

  27. DENG X, Xie S, Zhou M, Yuan Q, et al
    The RNA-binding protein RBM39 scaffolds an m(6)A-dependent RNA decay complex that destabilizes Tat transcripts and restricts HIV-1 reactivation.
    PLoS Biol. 2025;23:e3003486.
    PubMed         Abstract available


    PLoS One

  28. HOANG TH, Alvarez GG, Adermark L, Ng N, et al
    Exploring factors associated with dual tobacco smoking among people living with HIV receiving care at HIV outpatient clinics in Hanoi, Vietnam.
    PLoS One. 2025;20:e0336112.
    PubMed         Abstract available

  29. GEBRETSADIK GG, Biratu AK, Bayray Kahsay A, Gessessew A, et al
    Preconception care uptake and risk factors for adverse pregnancy outcomes among pregnant women in Tigray, northern Ethiopia: A community-based cross-sectional study.
    PLoS One. 2025;20:e0336255.
    PubMed         Abstract available


    PLoS Pathog

  30. KALDHUSDAL V, Franzen Boger M, Burgener AD, Lajoie J, et al
    The cervicovaginal microbiome associates with spatially restricted host transcriptional signatures throughout the human ectocervical epithelium and submucosa.
    PLoS Pathog. 2025;21:e1013677.
    PubMed         Abstract available

  31. ZHENG WH, Lin SY, He ZL, Ni RZ, et al
    CHIP/STUB1 suppresses the transcription and latent reactivation of HIV-1 via the TRAF6-NF-kappaB-HIV-LTR axis.
    PLoS Pathog. 2025;21:e1013683.
    PubMed         Abstract available


Thank you for your interest in scientific medicine.


AMEDEO HIV Infection is free of charge.